ADHD and EEG-Neurofeedback. A randomised placebo-controlled treatment study
- Conditions
- Attention-deficit / Hyperactivity Disorder (ADHD)10034726
- Registration Number
- NL-OMON32034
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 41
Diagnosis ADHD (classified by the DSM-IV TR)
Age between 8 and 15
A full scale IQ ³ 80
Medication- naïve, or using psychostimulants/atomoxetine but still with room for improvement
Currently intensive (i.e. weekly) individual or group psychotherapy.
Use of medication other than psychopharmaca
Diagnosis of one or more of the following comorbid psychiatric disorders:
Major depression or dysthymie
Anxiety disorder
Bipolar disorder
Psychotic disorder
Chronical motor tic disorder or Gilles de la Tourette
Conduct disorder
Autism spectrum disorders
Eating disorders
Cardiovascular disease currently/in the past
Neurological disorders (e.g. epilepsy) currently or in the past
Participation in another clinical trial simultaneously
Neurofeedback training in the past
Metal parts in body
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>ADHD-DSM-IV rating scale, rated by the investigator</p><br>
- Secondary Outcome Measures
Name Time Method <p>scores on all neuropsychological tasks<br /><br>absolute en relative power of 4 frequenties EEG bands<br /><br>fluctuations in de BOLD signals on fMRI<br /><br>measures on the diffusion Tensor Imaging (DTI)</p><br>